CPHI India and PMEC India 2026 are entering a new phase of growth with the introduction of a dual-venue format in the Delhi-NCR region. This strategic expansion reflects the increasing scale of the pharmaceutical industry and the need for more specialised and focused engagement platforms.
For the 2026 edition, the two events will be hosted at separate venues with overlapping schedules. CPHI India will take place from 23–25 November at the India International Convention and Expo Centre (Yashobhoomi) in New Delhi, while PMEC India will be held from 24–26 November at India Expo Mart in Greater Noida. This structure creates a continuous four-day business window, allowing participants to explore both events more efficiently.
Recognised for nearly two decades as a central meeting point for the pharmaceutical industry, the combined platform has consistently connected global and domestic stakeholders. The shift to a two-venue format marks a significant evolution, aligning with an industry that is becoming more technology-driven, specialised, and innovation-focused.
Each event will now offer a more targeted experience. CPHI India will continue to serve as a global hub for pharmaceutical ingredients, APIs, formulations, and related services, attracting manufacturers, biotech firms, and service providers. On the other hand, PMEC India will focus exclusively on machinery, equipment, and manufacturing technologies, including packaging, automation, and cleanroom solutions.
The decision to expand was driven by strong industry demand, as the event had outgrown a single venue. With increasing participation, both exhibitors and visitors required more space, time, and opportunities for meaningful interactions. The new format addresses these needs by offering improved accessibility, better segmentation, and enhanced networking potential across the entire pharma value chain.
Additionally, the overlapping schedule enables seamless movement between venues, allowing attendees to engage with a broader range of sectors without time constraints. This integrated yet specialised approach is expected to improve business outcomes, foster deeper collaborations, and deliver greater value for participants.
As India continues to strengthen its position as a global pharmaceutical leader, CPHI & PMEC India 2026 is set to play a key role in driving innovation, partnerships, and growth across the industry.
